» Articles » PMID: 29121074

Proteome Profiling in the Aorta and Kidney of Type 1 Diabetic Rats

Overview
Journal PLoS One
Date 2017 Nov 10
PMID 29121074
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes is associated with a number of metabolic and cardiovascular risk factors that contribute to a high rate of microvascular and macrovascular complications. The risk factors and mechanisms that contribute to the development of micro- and macrovascular disease in diabetes are not fully explained. In this study, we employed mass spectrometric analysis using tandem LC-MS/MS to generate a proteomic profile of protein abundance and post-translational modifications (PTM) in the aorta and kidney of diabetic rats. In addition, systems biology analyses were employed to identify key protein markers that can provide insights into molecular pathways and processes that are differentially regulated in the aorta and kidney of type 1 diabetic rats. Our results indicated that 188 (111 downregulated and 77 upregulated) proteins were significantly identified in the aorta of diabetic rats compared to normal controls. A total of 223 (109 downregulated and 114 upregulated) proteins were significantly identified in the kidney of diabetic rats compared to normal controls. When the protein profiles from the kidney and aorta of diabetic and control rats were analyzed by principal component analysis, a distinct separation of the groups was observed. In addition, diabetes resulted in a significant increase in PTM (oxidation, phosphorylation, and acetylation) of proteins in the kidney and aorta and this effect was partially reversed by insulin treatment. Ingenuity pathway analysis performed on the list of differentially expressed proteins depicted mitochondrial dysfunction, oxidative phosphorylation and acute phase response signaling to be among the altered canonical pathways by diabetes in both tissues. The findings of the present study provide a global proteomics view of markers that highlight the mechanisms and putative processes that modulate renal and vascular injury in diabetes.

Citing Articles

Research biopsies in kidney transplantation: an evaluation of surgical techniques and optimal tissue mass allowing molecular and histological analyses.

Shaheed S, McGivern H, Oliveira M, Snashall C, Sutton C, Tam K Clin Proteomics. 2024; 21(1):55.

PMID: 39271970 PMC: 11401365. DOI: 10.1186/s12014-024-09508-2.


Comparative Transcriptomics and Proteomics of Cancer Cell Lines Cultivated by Physiological and Commercial Media.

Wang J, Peng W, Yu A, Fokar M, Mechref Y Biomolecules. 2022; 12(11).

PMID: 36358924 PMC: 9687725. DOI: 10.3390/biom12111575.


Maternal serum proteomic profiles of pregnant women with type 1 diabetes.

Gutaj P, Matysiak J, Matuszewska E, Jaskiewicz K, Kaminska D, Swiatly-Blaszkiewicz A Sci Rep. 2022; 12(1):8696.

PMID: 35610262 PMC: 9130255. DOI: 10.1038/s41598-022-12221-5.


Proteomic Study of Low-Birth-Weight Nephropathy in Rats.

Imasawa T, Claverol S, Lacombe D, Dias Amoedo N, Rossignol R Int J Mol Sci. 2021; 22(19).

PMID: 34638634 PMC: 8508940. DOI: 10.3390/ijms221910294.


Investigation of proteins important for microcirculation using in vivo microdialysis after glucose provocation: a proteomic study.

Hogstedt A, Farnebo S, Tesselaar E, Ghafouri B Sci Rep. 2021; 11(1):19093.

PMID: 34580391 PMC: 8476624. DOI: 10.1038/s41598-021-98672-8.


References
1.
Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

2.
Dong W, Chao M, Lu Q, Chai W, Zhang W, Chen X . Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy. Oncotarget. 2015; 7(1):66-80. PMC: 4807983. DOI: 10.18632/oncotarget.6384. View

3.
Fokkens B, Mulder D, Schalkwijk C, Scheijen J, Smit A, Los L . Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls. PLoS One. 2017; 12(3):e0173379. PMC: 5338797. DOI: 10.1371/journal.pone.0173379. View

4.
Van J, Scholey J, Konvalinka A . Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics. J Am Soc Nephrol. 2017; 28(4):1050-1061. PMC: 5373465. DOI: 10.1681/ASN.2016091018. View

5.
Matsuyama Y, Terawaki H, Terada T, Era S . Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease. Clin Exp Nephrol. 2009; 13(4):308-315. DOI: 10.1007/s10157-009-0161-y. View